David D Schlaepfer Selected Research

Neurofibromatosis 2 (Neurofibromatosis Type II)

7/2014

Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David D Schlaepfer Research Topics

Disease

29	Neoplasms (Cancer) 01/2022 - 02/2002
11	Carcinoma (Carcinomatosis) 06/2015 - 07/2004
9	Neoplasm Metastasis (Metastasis) 01/2015 - 12/2002
7	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 06/2013
4	Carcinogenesis 01/2020 - 03/2003
3	Inflammation (Inflammations) 01/2023 - 06/2007
3	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 01/2011
3	Breast Neoplasms (Breast Cancer) 05/2010 - 02/2010
2	Fibrosis (Cirrhosis) 01/2023 - 01/2016
2	Atherosclerosis 12/2021 - 04/2016
2	Melanoma (Melanoma, Malignant) 01/2018 - 01/2014
2	Ascites 08/2014 - 05/2010
1	Obesity 01/2023
1	Hyperplasia 01/2019
1	Uveal melanoma 01/2019
1	Pancreatic Ductal Carcinoma 01/2016
1	Adenoma (Adenomas) 09/2015
1	Neuroblastoma 01/2015
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 07/2014
1	Mesothelioma 07/2014
1	Wounds and Injuries (Trauma) 01/2012
1	Splenomegaly 05/2010
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2009
1	Infections 02/2009
1	Glioma (Gliomas) 01/2006
1	Multiple Myeloma 07/2004
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2004
1	Achondroplasia 07/2004

Drug/Important Bio-Agent (IBA)

12	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2022 - 03/2003
12	IntegrinsIBA 01/2018 - 01/2006
9	Tyrosine (L-Tyrosine)FDA Link 01/2022 - 03/2003
7	Phosphotransferases (Kinase)IBA 01/2019 - 01/2006
7	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2007
6	Messenger RNA (mRNA)IBA 01/2022 - 06/2007
3	CateninsIBA 01/2019 - 09/2015
3	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 04/2016 - 06/2012
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2014 - 06/2013
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2009 - 07/2004
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 01/2012
2	GastrinsIBA 06/2015 - 01/2011
2	PaxillinIBA 06/2015 - 01/2011
2	Fibronectins (Fibronectin)IBA 01/2015 - 01/2012
2	AgarIBA 08/2014 - 12/2002
2	Biomarkers (Surrogate Marker)IBA 08/2014 - 07/2014
2	Small Interfering RNA (siRNA)IBA 07/2014 - 06/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 10/2006
2	Epidermal Growth Factor (EGF)IBA 01/2012 - 02/2009
2	PND 1186IBA 05/2010 - 05/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2010 - 06/2007
2	Interleukin-6 (Interleukin 6)IBA 05/2010 - 06/2007
2	Drinking WaterIBA 05/2010 - 05/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2023
1	Extracellular Matrix ProteinsIBA 01/2023
1	LigandsIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	DNA Methyltransferase 3AIBA 12/2021
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2020
1	Cyclin D1IBA 01/2019
1	GTP-Binding Proteins (G-Protein)IBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	Aldehyde DehydrogenaseIBA 01/2019
1	PlatinumIBA 01/2019
1	VemurafenibIBA 01/2018
1	oxidized low density lipoproteinIBA 04/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2016
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 06/2015
1	Indicators and Reagents (Reagents)IBA 01/2015
1	OsteopontinIBA 08/2014
1	Neurofibromin 2 (Merlin)IBA 07/2014
1	cadherin 5IBA 01/2014
1	TalinIBA 07/2012
1	GTP Phosphohydrolases (GTPases)IBA 01/2012
1	Glycoproteins (Glycoprotein)IBA 01/2012
1	tyrosine receptor (receptor, tyrosine)IBA 01/2012
1	Hormones (Hormone)IBA 01/2011
1	Growth Factor ReceptorsIBA 01/2011
1	CytokinesIBA 05/2010
1	Caspase 3 (Caspase-3)IBA 05/2010
1	Steroid Receptors (Steroid Receptor)IBA 02/2010
1	Protein Isoforms (Isoforms)IBA 02/2010
1	p120 GTPase Activating ProteinIBA 06/2009
1	ErbB Receptors (EGF Receptor)IBA 02/2009
1	Monomeric GTP-Binding ProteinsIBA 02/2009
1	integrin alphaVbeta5IBA 02/2009
1	CC ChemokinesIBA 02/2009
1	Peptide Hydrolases (Proteases)FDA Link 10/2006
1	Protein Kinases (Protein Kinase)IBA 01/2006
1	FAK-related nonkinaseIBA 01/2006
1	Metalloproteases (Metalloproteinases)IBA 01/2006
1	integrin alphavbeta1IBA 01/2006
1	Angiopoietin-2IBA 01/2006
1	Focal Adhesion Kinase 2IBA 07/2004
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 07/2004

Therapy/Procedure

5	Therapeutics 01/2018 - 08/2008
1	Immunotherapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2019
1	Adjuvant Chemotherapy 01/2019
1	Radiotherapy 01/2018
1	Oral Administration 05/2010